Helix Acquisition Corp
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $100M
- Underwriters
- Focus
- Healthcare
- SEC Filings
- 1821586
- Public Embarc Page
- https://embarc.com/capital/spac/1821586/HLXA/helix-acquisition
- IPO Ticker
- HLXA
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and ChairmanBihua Chen
- Chief Financial OfficerJay Scollins
- DirectorNancy Chang
- DirectorWill Lewis
- DirectorJohn Schmid
Target Information
Information on the SPAC target for merger.
- Company
- MoonLake Immunotherapeutics AG
- Presentation
- Investor Presentation (SEC) on 2022-01-19
- New Ticker
- MLTX
- Description
- MoonLake Immunotherapeutics is "a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases."